EE239 How to Consider Caregiver Health-Related Quality of Life in a Cost-Effectiveness Analysis? An Illustration with Dupilumab for the Treatment of Severe Atopic Dermatitis in Infants in France
Abstract
Authors
L. Sutour J. Tardu N. Virely M. Sivignon N. Allali J. Tavi A.L. Vataire